A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Trial Profile

A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Metformin (Primary) ; Ritonavir (Primary)
  • Indications Chronic lymphocytic leukaemia; Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Mar 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
    • 09 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top